Health Care Equipment

Autonomix Medical

Autonomix Medical released FY2026 Q2 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.3799 (forecast USD -1.5)

Autonomix Medical released FY2026 Q1 earnings on August 13, 2025 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.0746 (forecast USD -0.98)

Autonomix Medical Inc Secures New US Patent

Autonomix Medical Expands Clinical Research for Visceral Cancer Pain with Ethics Committee Approval

Autonomix Medical released FY2025 earnings on May 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -6.4593 (forecast USD -3.955)

Autonomix Medical released FY2025 Q4 earnings on May 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.1596 (forecast USD -1.235)

Autonomix Medical Releases Annual Financial Report

Autonomix Obtains New Patent

Autonomix's Pain Treatment Trial Significantly Reduces Pain Levels

Autonomix Medical Reports Positive Results in Pancreatic Cancer Pain Management Trial

Autonomix Medical released FY2025 Q3 earnings on February 13, 2025 (EST), with actual revenue of 0 USD and EPS of -1.4644 USD (forecast EPS was -2.4 USD)

Autonomix Medical released FY2025 9 Months Earnings on February 13 (EST) with actual revenue of 0 USD and EPS of -6.7879 USD

Autonomix Medical Announces CEO Corner Program Discussing Insights from J.P. Morgan Healthcare Conference

Autonomix Medical released FY2025 Semi-Annual Earnings on November 8, 2024 (EST) with actual revenue of 0 and EPS of -5.2843

Autonomix Medical released FY2025 Q2 earnings on November 8 (EST) with actual EPS of -2.4677 and no reported revenue

Autonomix Medical, Inc. (NASDAQ: AMIX) announces positive results from human clinical trial for pancreatic cancer pain treatment

Autonomix Medical released FY2025 Q1 earnings on August 13 (EST) with actual revenue of USD 0 and EPS of USD -2.2025

Autonomix Medical released FY2024 Annual Earnings on May 31 (EST), actual revenue USD 0, actual EPS USD -14.8224

Autonomix Medical released FY2024 Q4 earnings on May 31 (EST) with actual revenue of USD 0 and EPS of USD -4.6489

Autonomix Medical Inc recruits first participants for pancreatic cancer clinical trial

Alpha Tech

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

WeShop

PACS

Intchains

Annovis Bio

K Wave Media

Applied Therapeutics

Scripps

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap